Evaluation of the Cica Fungi Test Candida, a Novel Serum Candida mannan antigen kit, and its comparison with Cand-Tec in candidemia patients

Japanese Journal of Infectious Diseases

Volumn 64, Issue 2, 2011, Pages 116-120

  Takazono, Takahiro ^a,b   Izumikawa, Koichi ^a,b   Nagayoshi, Yosuke ^a,b   Tanaka, Akitaka ^a,b   Mihara, Tomo ^a,b   Kosai, Kosuke ^a,b   Saijo, Tomomi ^a,b   Imamura, Yoshifumi ^a,b   Miyazaki, Taiga ^a,b   Seki, Masafumi ^a,b   Kakeya, Hiroshi ^a,b   Yamamoto, Yoshihiro ^a,b   Yanagihara, Katsunori ^b,c   Kamihira, Shimeru ^c   Kohno, Shigeru ^a,b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CANDIDEMIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC KIT; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FUNGAL DETECTION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LATEX AGGLUTINATION TEST; MALE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, FUNGAL; CANDIDEMIA; CLINICAL LABORATORY TECHNIQUES; FEMALE; HUMANS; IMMUNOASSAY; INFANT; JAPAN; MALE; MANNANS; MIDDLE AGED; MYCOLOGY; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 79955604169     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Almirante, B., Rodŕi{dotless}guez, D., Park, B.J., et al. (2005): Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J. Clin. Microbiol., 43, 1829-1835.
2. Colombo, A.L., Nucci, M., Park, B.J., et al. (2006): Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J. Clin. Microbiol., 44, 2816-2823.
3. Blumberg, H.M., Jarvis, W.R., Soucie, J.M., et al. (2001): Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin. Infect. Dis., 33, 177-186.
4. Fraser, V.J., Jones, M., Dunkel, J., et al. (1992): Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis., 15, 414-421.
5. Falagas, M.E., Apostolou, K.E. and Pappas, V.D. (2006): Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur. J. Clin. Microbiol. Infect. Dis., 25, 419-425.
6. Garey, K.W., Rege, M., Pai, M.P., et al. (2006): Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis., 43, 25-31.
7. Nolla-Salas, J., Sitges-Serra, A., Leon-Gil, C., et al. (1997): Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med., 23, 23-30.
8. Groll, A.H., Shah, P.M., Mentzel, C., et al. (1996): Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect., 33, 23-32.
9. Ben-Ami, R., Weinberger, M., Orni-Wasserlauff, R., et al. (2008): Time to blood culture positivity as a marker for catheter-related candidemia. J. Clin. Microbiol., 46, 2222-2226.
10. Bille, J., Edson, R.S. and Roberts, G.D. (1984): Clinical evaluation of the lysis-centrifugation blood culture system for the detection of fungemia and comparison with a conventional biphasic broth blood culture system. J. Clin. Microbiol., 19, 126-128.
11. Sendid, B., Tabouret, M., Poirot, J.L., et al. (1999): New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J. Clin. Microbiol., 37, 1510-1517.
12. Yeo, S.F. and Wong, B. (2002): Current status of nonculture methods for diagnosis of invasive fungal infections. Clin. Microbiol. Rev., 15, 465-484.
13. Obayashi, T., Yoshida, M., Mori, T., et al. (1995): Plasma (1→3)-β-Dglucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet, 345, 17-20.
14. Sendid, B., Poirot, J.L., Tabouret, M., et al. (2002): Combined detection of mannanaemia and anti-mannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J. Med. Microbiol., 51, 433-442.
15. Reiss, E. and Morrison, C.J. (1993): Nonculture methods for diagnosis of disseminated candidiasis. Clin. Microbiol. Rev., 6, 311-323.
16. Fujita, S., Takamura, T., Nagahara, M., et al. (2006): Evaluation of a newly developed down-flow immunoassay for detection of serum mannan antigens in patients with candidaemia. J. Med. Microbiol., 55, 537-543.
17. Gentry, L.O., Wilkinson, I.D., Lea, A.S., et al. (1983): Latex agglutination test for detection of Candida antigen in patients with disseminated disease. Eur. J. Clin. Microbiol., 2, 122-128.
18. Persat, F., Ranque, S., Derouin, F., et al. (2008): Contribution of the (1→3)-β-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol., 46, 1009-1013.
19. De Pauw, B., Walsh, T.J., Donnelly, J.P., et al. (2008): Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis., 46, 1813-1821.
20. Ellis, M., Al-Ramadi, B., Bernsen, R., et al. (2009): Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J. Med. Microbiol., 58, 606-615.